All In Biotech

Free tool

FAERS Monitor: Nilstat

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 21, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050299 or its brand name (Nilstat, Nystatin). Reports on generic versions are filed under their own applications.

Reports

26,454

Serious

20,553

78% of reports

Hospitalization

11,878

Death reported

3,637

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea2,017
  • fatigue1,786
  • diarrhoea1,783
  • pneumonia1,643
  • dyspnoea1,487
  • off label use1,475
  • vomiting1,390
  • drug ineffective1,259
  • pain1,225
  • death1,152
  • pyrexia1,134
  • headache1,022
  • cough957
  • rash944
  • acute kidney injury936

Reports by year received

View as table
YearReports
2004282
2005330
2006365
2007339
2008351
2009434
2010529
2011607
2012748
2013697
2014889
20151,327
20161,672
20171,666
20182,073
20192,196
20202,309
20211,793
20221,654
20231,690
20241,632
20251,651
20261,219

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,027,705 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
acute kidney injurySignal9364.94.62,893
pneumoniaSignal1,6434.13.93,811
coughSignal9572.72.61,049
pyrexiaSignal1,1342.62.51,141
vomitingSignal1,3902.42.21,103
diarrhoeaSignal1,7832.22.11,199
dyspnoeaSignal1,4872.12.0867
nauseaSignal2,0172.01.91,090
fatigue1,7861.81.7690
rash9441.71.6291
pain1,2251.61.5273
off label use1,4751.31.3132
headache1,0221.31.271
death1,1521.11.04
drug ineffective1,2590.80.7102

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.